分红方面，博苑股份A股上市后累计派现8840.80万元。 资料显示，山东博苑医药化学股份有限公司位于山东省寿光市侯镇海洋化工园区新海路与大九路路口北 200米，成立日期2008年8月6日，上市日期2024年12月11日，公司主营业务涉及专业从事精细化学品研 发、生产、销售及资源综合利用的高新技术企业,主营业务包括有机碘化物、无机碘化物、贵金属催化 剂、发光材料、六甲基二硅氮烷等产品的研发、生产、销售,并基于资源综合利用资质与工艺技术优势 开展含碘、贵金属等物料的回收利用业务,为客户提供贵金属催化剂、六甲基二硅氮烷等加工服务。主 营业务收入构成为：碘化物74.56%，特种功能化学品12.79%，贸易业务9.94%，其他2.72%。 截至8月20日，博苑股份股东户数1.32万，较上期减少0.14%；人均流通股2524股，较上期增加0.14%。 2025年1月-6月，博苑股份实现营业收入7.47亿元，同比增长7.39%；归母净利润9904.29万元，同比减少 19.09%。 8月22日，博苑股份涨8.61%，成交额5.98亿元。两融数据显示，当日博苑股份获融资买入额8520.40万 元，融资偿还4878.64万元， ...

Group 1 - The core viewpoint of the news is that Hongshang Asset has conducted research on a listed company, Boyuan Co., focusing on its increased R&D investment and technological innovation strategies [1] - Boyuan Co. plans to enhance its R&D capabilities by increasing investment and expanding its R&D team, particularly by attracting high-end technical talent [1] - The company’s main products include inorganic iodides such as potassium iodide, potassium iodate, sodium iodide, and hydrogen iodide, which are used in pharmaceuticals, pesticides, feed, and optoelectronic materials [1] Group 2 - Boyuan Co.'s organic iodide product, trimethyl iodide, is primarily used as a protecting group in organic synthesis, especially in the production of antibiotics [1] - The pricing of iodide products is mainly based on the market price of refined iodine, determined through negotiations with customers [1] - The company is working on a high-end organic iodine and bromine new materials project with an annual capacity of 4,100 tons, which includes products like methyl iodide and dimethyl iodide [1]